OCTGT

AcronymDefinition
OCTGTOffice of Cellular Tissue and Gene Therapies (US FDA)
References in periodicals archive ?
Prior to Pharmanet, Dr Frey-Vasconcells worked for over 12 years at the FDA, including role of deputy director, Office of Cellular, Tissue, and Gene Therapies (OCTGT) with the Center for Biologics Evaluation and Research (CBER) as well as the regulatory expert for Cell Therapies.
She was in the Division of Human Tissues, Office of Cellular, Tissue and Gene Therapies (OCTGT), Centers for Biologics Evaluation and Research (CBER) when she announced her retirement.
The subcommittee will listen to presentations about the research program at the Office of Cellular, Tissue and Gene Therapies (OCTGT), Centers for Biologics Evaluation and Research (CBER).